Back to Search
DAVID HURST, MD
MD
Radiation Oncology Physician
NPI: 1518999564Individual
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
A43279(CA)ME54431(FL)
Research & Publications (20)
Inhibition of enzyme activity of and cell-mediated substrate cleavage by membrane type 1 matrix metalloproteinase by newly developed mercaptosulphide inhibitors.
PMID 16026329·Biochem J·2005
8-other
Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activities.
PMID 14533979·Biochem J·2004
8-other
The impact of atopy on neutrophil activity in middle ear effusion from children and adults with chronic otitis media.
PMID 12003588·Arch Otolaryngol Head Neck Surg·2002
8-other
Development and characterization of a new polyclonal antibody specifically against tissue inhibitor of metalloproteinases 4 in human breast cancer.
PMID 11178975·Biochem Biophys Res Commun·2001
8-other
Discovery of sodium 6-[(5-chloro-2-{[(4-chloro-2-fluorophenyl)methyl]oxy}phenyl)methyl]-2-pyridinecarboxylate (GSK269984A) an EP(1) receptor antagonist for the treatment of inflammatory pain.
PMID 19332369·Bioorg Med Chem Lett·2009
7-preclinical
Nuclear magnetic resonance and circular dichroism study of metastin (Kisspeptin-54) structure in solution.
PMID 19308666·Clin Exp Metastasis·2009
8-other
Multiple forms of BRMS1 are differentially expressed in the MCF10 isogenic breast cancer progression model.
PMID 18841483·Clin Exp Metastasis·2009
7-preclinical
Inhibition of CXCR4 by CTCE-9908 inhibits breast cancer metastasis to lung and bone.
PMID 19212637·Oncol Rep·2009
7-preclinical
Analogs of JHU75528, a PET ligand for imaging of cerebral cannabinoid receptors (CB1): development of ligands with optimized lipophilicity and binding affinity.
PMID 18511157·Eur J Med Chem·2009
8-other
Over-expression of the BRMS1 family member SUDS3 does not suppress metastasis of human cancer cells.
PMID 19070953·Cancer Lett·2009
7-preclinical
Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis.
PMID 19190326·Cancer Res·2009
8-other
Discovery of GSK345931A: An EP(1) receptor antagonist with efficacy in preclinical models of inflammatory pain.
PMID 19036582·Bioorg Med Chem Lett·2009
7-preclinical
Breast cancer metastasis suppressor 1 coordinately regulates metastasis-associated microRNA expression.
PMID 19585508·Int J Cancer·2009
8-other
Ligand-binding architecture of human CB2 cannabinoid receptor: evidence for receptor subtype-specific binding motif and modeling GPCR activation.
PMID 19022181·Chem Biol·2008
8-other
Metastasis Research Society-American Association For Cancer Research Joint Conference on Metastasis.
PMID 19047132·Cancer Res·2008
7-preclinical
Non-acidic pyrazole EP1 receptor antagonists with in vivo analgesic efficacy.
PMID 18462938·Bioorg Med Chem Lett·2008
7-preclinical
Does treatment with inhaled corticosteroids improve outcomes in infants with RSV infection?
PMID 18472710·J Okla State Med Assoc·2008
8-other
Efficacy of allergy immunotherapy as a treatment for patients with chronic otitis media with effusion.
PMID 18541312·Int J Pediatr Otorhinolaryngol·2008
8-other
Breast cancer metastasis suppressor-1 differentially modulates growth factor signaling.
PMID 18664570·J Biol Chem·2008
8-other
Residues accessible in the binding-site crevice of transmembrane helix 6 of the CB2 cannabinoid receptor.
PMID 19053233·Biochemistry·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 3031 Carters Mill Rd
Marianna, FL 32446 - Phone
- (850) 265-5632
Quick Facts
- NPI
- 1518999564
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 3
- Publications
- 20
Are you this provider?
Claim Your Profile